6-hydroxy-5-methoxy-2-indolylcarboxylic acid has been researched along with Psoriasis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronsson, A; Hansson, C; Rorsman, H; Rosengren, E; Wirestrand, LE | 1 |
1 other study(ies) available for 6-hydroxy-5-methoxy-2-indolylcarboxylic acid and Psoriasis
| Article | Year |
|---|---|
Urinary excretion of 6-hydroxy-5-methoxyindole-2-carboxylic acid and 5-S-cysteinyldopa during PUVA treatment.
Topics: Adult; Cysteinyldopa; Dihydroxyphenylalanine; Female; Humans; Indoles; Kinetics; Male; Middle Aged; Photochemotherapy; Psoriasis; PUVA Therapy | 1985 |